No. of Pages: 210 | Report Code: TIPRE00022774 | Category: Technology, Media and Telecommunications
1.1 Report Guidance
1.2 Market Segmentation
2.1 Key Insights
2.2 Market Attractiveness
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
3.3 Assumptions and Limitations
4.1 Overview
4.1.1 Software/Service Providers:
4.1.2 System Integrators:
4.1.3 Regulatory Bodies:
4.1.4 End-Users:
4.2 List of Vendors in the Value Chain
5.1
5.1 Market Drivers
5.1.1 Rise in Incidences of Adverse Drug Reactions
5.1.2 Globalization of Pharmacovigilance
5.1.3 Surge in Drug Development Spending
5.2 Market Restraints
5.2.1 High Installation and Maintenance Costs
5.3 Market Opportunities
5.3.1 Integration of Software with AI, ML, and NLP
5.4 Future Trends
5.4.1 Cloud-Based Pharmacovigilance and Drug Safety Software:
5.5 Impact of Drivers and Restraints:
6.1 North America Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021–2031
6.2 North America Pharmacovigilance and Drug Safety Software Market Forecast Analysis
7.1 Software
7.1.1 Overview
7.1.2 Software: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
7.2 Services
7.2.1 Overview
7.2.2 Services: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
8.1 Cloud
8.1.1 Overview
8.1.2 Cloud: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
8.2 On Premises
8.2.1 Overview
8.2.2 On Premises: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
9.1 Large Enterprises
9.1.1 Overview
9.1.2 Large Enterprises: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
9.2 SMEs
9.2.1 Overview
9.2.2 SMEs: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
10.1 Standard
10.1.1 Overview
10.1.2 Standard: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
10.2 Customized
10.2.1 Overview
10.2.2 Customized: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.1 Signal and Risk Management
11.1.1 Overview
11.1.2 Signal and Risk Management: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.2 Issue Tracking and Adverse Event Tracking
11.2.1 Overview
11.2.2 Issue Tracking and Adverse Event Tracking: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.3 Case Management
11.3.1 Overview
11.3.2 Case Management: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.4 Clinical Safety Management and Clinical Trial Safety
11.4.1 Overview
11.4.2 Clinical Safety Management and Clinical Trial Safety: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.5 Quality and Compliance
11.5.1 Overview
11.5.2 Quality and Compliance: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.6 Medical Writing
11.6.1 Overview
11.6.2 Medical Writing: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.7 Audit Support and Training Compliance
11.7.1 Overview
11.7.2 Audit Support and Training Compliance: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.8 Healthcare Analytics
11.8.1 Overview
11.8.2 Healthcare Analytics: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.9 Others
11.9.1 Overview
11.9.2 Others: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
12.1 Pharmaceutical and Biotechnology Companies
12.1.1 Overview
12.1.2 Pharmaceutical and Biotechnology Companies: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
12.2 Contract Research Organizations
12.2.1 Overview
12.2.2 Contract Research Organizations: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
12.3 Business Process Outsourcing (BPO) Firms
12.3.1 Overview
12.3.2 Business Process Outsourcing (BPO) Firms: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
12.4 Others
12.4.1 Overview
12.4.2 Others: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1 North America
13.1.1 North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.1.1.1 North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.1.1.2 United States: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1.1.2.1 United States: North America Pharmacovigilance and Drug Safety Software Market Share – by Offering
13.1.1.2.1 United States: North America Pharmacovigilance and Drug Safety Software Market Share – by Deployment
13.1.1.2.2 United States: North America Pharmacovigilance and Drug Safety Software Market Share – by Enterprise Size
13.1.1.2.3 United States: North America Pharmacovigilance and Drug Safety Software Market Share – by Form
13.1.1.2.4 United States: North America Pharmacovigilance and Drug Safety Software Market Share – by Functionality
13.1.1.2.5 United States: North America Pharmacovigilance and Drug Safety Software Market Share – by End User
13.1.1.3 Canada: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1.1.3.1 Canada: North America Pharmacovigilance and Drug Safety Software Market Share – by Offering
13.1.1.3.2 Canada: North America Pharmacovigilance and Drug Safety Software Market Share – by Deployment
13.1.1.3.3 Canada: North America Pharmacovigilance and Drug Safety Software Market Share – by Enterprise Size
13.1.1.3.4 Canada: North America Pharmacovigilance and Drug Safety Software Market Share – by Form
13.1.1.3.5 Canada: North America Pharmacovigilance and Drug Safety Software Market Share – by Functionality
13.1.1.3.6 Canada: North America Pharmacovigilance and Drug Safety Software Market Share – by End User
13.1.1.4 Mexico: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1.1.4.1 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share – by Offering
13.1.1.4.2 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share – by Deployment
13.1.1.4.3 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share – by Enterprise Size
13.1.1.4.4 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share – by Form
13.1.1.4.5 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share – by Functionality
13.1.1.4.6 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share – by End User
14.1 Heat Map Analysis by Key Players
14.2 Company Positioning and Concentration
15.1 Overview
15.2 Market Initiative
15.3 Partnerships and Collaborations
16.1 ArisGlobal LLC
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Max Application
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Oracle Corp
16.3.1 Key Facts
16.3.1 Business Description
16.3.2 Products and Services
16.3.3 Financial Overview
16.3.4 SWOT Analysis
16.3.5 Key Developments
16.4 Veeva Systems Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 IQVIA Holdings Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 ICON Plc
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Cognizant Technology Solutions Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Accenture Plc
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Syneos Health Inc
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Genpact Ltd.
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
16.11 AB Cube S.A.S.
16.11.1 Key Facts
16.11.2 Business Description
16.11.3 Products and Services
16.11.4 Financial Overview
16.11.5 SWOT Analysis
16.11.6 Key Developments
16.12 Laboratory Corp of America Holdings
16.12.1 Key Facts
16.12.2 Business Description
16.12.3 Products and Services
16.12.4 Financial Overview
16.12.5 SWOT Analysis
16.12.6 Key Developments
16.13 Parexel International Corp
16.13.1 Key Facts
16.13.2 Business Description
16.13.3 Products and Services
16.13.4 Financial Overview
16.13.5 SWOT Analysis
16.13.6 Key Developments
16.14 Qinecsa Solutions
16.14.1 Key Facts
16.14.2 Business Description
16.14.3 Products and Services
16.14.4 Financial Overview
16.14.5 SWOT Analysis
16.14.6 Key Developments
16.15 Clinevo Technologies
16.15.1 Key Facts
16.15.2 Business Description
16.15.3 Products and Services
16.15.4 Financial Overview
16.15.5 SWOT Analysis
16.15.6 Key Developments
17.1 About Us
17.2 List of Abbreviations
Table 1. North America Pharmacovigilance and Drug Safety Software Market Segmentation
Table 2. List of Vendors
Table 3. North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Table 4. North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Offering
Table 5. North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Deployment
Table 6. North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Enterprise Size
Table 7. North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Form
Table 8. North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Functionality
Table 9. North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by End User
Table 10. North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Country
Table 11. United States: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Offering
Table 12. United States: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Deployment
Table 13. United States: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Enterprise Size
Table 14. United States: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Form
Table 15. United States: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Functionality
Table 16. United States: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by End User
Table 17. Canada: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Offering
Table 18. Canada: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Deployment
Table 19. Canada: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Enterprise Size
Table 20. Canada: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Form
Table 21. Canada: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Functionality
Table 22. Canada: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by End User
Table 23. Mexico: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Offering
Table 24. Mexico: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Deployment
Table 25. Mexico: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Enterprise Size
Table 26. Mexico: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Form
Table 27. Mexico: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Functionality
Table 28. Mexico: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by End User
Table 29. List of Abbreviations
Figure 1. North America Pharmacovigilance and Drug Safety Software Market Segmentation – Country
Figure 2. Ecosystem Analysis
Figure 3. North America Pharmacovigilance and Drug Safety Software Market – Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021–2031
Figure 6. North America Pharmacovigilance and Drug Safety Software Market Share (%) – by Offering (2023 and 2031)
Figure 7. Software: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 8. Services: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 9. North America Pharmacovigilance and Drug Safety Software Market Share (%) – by Deployment (2023 and 2031)
Figure 10. Cloud: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 11. On Premises: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 12. North America Pharmacovigilance and Drug Safety Software Market Share (%) – by Enterprise Size (2023 and 2031)
Figure 13. Large Enterprises: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 14. SMEs: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 15. North America Pharmacovigilance and Drug Safety Software Market Share (%) – by Form (2023 and 2031)
Figure 16. Standard: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 17. Customized: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 18. North America Pharmacovigilance and Drug Safety Software Market Share (%) – by Functionality (2023 and 2031)
Figure 19. Signal and Risk Management: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 20. Issue Tracking and Adverse Event Tracking: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 21. Case Management: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 22. Clinical Safety Management and Clinical Trial Safety: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 23. Quality and Compliance: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 24. Medical Writing: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 25. Audit Support and Training Compliance: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 26. Healthcare Analytics: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 27. Others: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 28. North America Pharmacovigilance and Drug Safety Software Market Share (%) – by End User (2023 and 2031)
Figure 29. Pharmaceutical and Biotechnology Companies: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 30. Contract Research Organizations: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 31. Business Process Outsourcing (BPO) Firms: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 32. Others: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 33. North America Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 34. United States: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021– 2031 (US$ Thousand)
Figure 35. Canada: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021– 2031 (US$ Thousand)
Figure 36. Mexico: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021– 2031 (US$ Thousand)
Figure 37. Heat Map Analysis by Key Players
Figure 38. Company Positioning and Concentration
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Pharmacovigilance and Drug Safety Software Market
